In mice, Hawiger et al demonstrated that anti-CD5 blocking antibodies, or the use of CD5-/- transgenic MOG-specific T cells, resulted in higher sensitivity to experimental autoimmune encephalitis (Hawiger et al., 2004). The gene discussed is MOG; the disease is autoimmune encephalitis.